ONO-7018 + ONO-7018
Phase 1Active 0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Lymphoma, Non-Hodgkin
Conditions
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Trial Timeline
Feb 13, 2023 → Dec 1, 2027
NCT ID
NCT05515406About ONO-7018 + ONO-7018
ONO-7018 + ONO-7018 is a phase 1 stage product being developed by Ono Pharmaceutical for Lymphoma, Non-Hodgkin. The current trial status is active. This product is registered under clinical trial identifier NCT05515406. Target conditions include Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell.
What happened to similar drugs?
18 of 20 similar drugs in Lymphoma, Non-Hodgkin were approved
Approved (18) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
6
Activity
12
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05515406 | Phase 1 | Active |
Competing Products
20 competing products in Lymphoma, Non-Hodgkin